Compounds > tenofovir
Page last updated: 2024-08-24

tenofovir and Recrudescence

tenofovir has been researched along with Recrudescence in 62 studies

Research

Studies (62)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (8.06)29.6817
2010's36 (58.06)24.3611
2020's21 (33.87)2.80

Authors

AuthorsStudies
Brakenhoff, SM; Chan, HLY; Chen, CH; Chien, RN; Choi, HSJ; Cornberg, M; Feld, J; Forns, X; Hansen, BE; Hirode, G; Hsu, YC; Janssen, HLA; Jeng, WJ; Kao, JH; Lens, S; Papatheodoridi, M; Papatheodoridis, GV; Seto, WK; Sonneveld, MJ; Su, TH; Van Hees, S; Vanwolleghem, T; Wong, G; Yuen, MF1
Chen, CH; Hu, TH; Hung, CH; Kuo, YH; Lu, SN; Peng, CY; Wang, JH1
Chien, RN; Liaw, YF1
Chen, CH; Hu, TH; Hung, CH; Kuo, YH; Lu, SN; Tseng, TN; Wang, JH1
Brakenhoff, SM; Chan, HLY; Chen, CH; Chien, RN; Choi, HSJ; Cornberg, M; Feld, JJ; Forns, X; Hansen, BE; Hirode, G; Hsu, YC; Janssen, HLA; Jeng, WJ; Kao, JH; Lens, S; Papatheodoridi, M; Papatheodoridis, GV; Seto, WK; Sonneveld, MJ; Su, TH; Van Hees, S; Vanwolleghem, T; Wong, GLH; Yuen, MF1
Chien, RN; Jeng, WJ; Liaw, YF; Liu, YC; Peng, CW; Yang, HI1
Chang, KC; Chen, CH; Chiu, SM; Hu, TH; Hung, CH; Lu, SN; Wang, JH1
Liaw, YF; Liu, YC1
Chen, CH; Hu, TH; Hung, CH; Jeng, WJ; Lu, SN; Tseng, TN; Wang, JH1
Chen, CH; Chien, RN; Hu, TH; Hung, CH; Jeng, WJ; Liu, YC; Lu, SN; Wang, JH1
Chen, CH; Fang, HW; Hu, TH; Hung, CH; Lu, SN; Wang, JH1
Chen, CL; Chen, PJ; Hong, CM; Kao, JH; Lin, MJ; Liou, JM; Liu, CH; Liu, CJ; Su, TH; Tseng, TC; Yang, HC1
Chen, CH; Hu, TH; Hung, CH; Lu, SN; Peng, CY; Wang, JH1
Chen, YC; Chien, RN; Hsu, CW1
Chen, CH; Hu, TH; Hung, CH; Lu, SN; Ma, TL; Wang, JH1
Bai, X; Chen, X; Fan, R; Hou, J; Niu, J; Peng, J; Ren, H; Sheng, J; Sun, J; Tan, D; Tang, H; Wang, H; Wang, M; Wu, Y; Xie, Q; Xu, M; Zhou, B1
Chang, KK; Kuo, MJ; Lin, RC; Tseng, YT; Wang, CH; Yang, CC1
Chen, CH; Hu, TH; Hung, CH; Jeng, WJ; Kuo, YH; Lu, SN; Tseng, TN; Wang, JH1
Chang, WY; Chen, DS; Chen, PJ; Cheng, PN; Chiu, FW; Chiu, YC; Hsu, YC; Kao, JH; Liu, CH; Liu, CJ; Su, TH; Tseng, TC; Yang, HC; Yang, SS1
Cholongitas, E; Orfanidou, A; Papatheodoridis, GV1
Chang, SH1
Chen, CH; Fang, HW; Hu, TH; Hung, CH; Lu, SN; Wang, JH; Yen, YH1
Chan, HL; Chan, RS; Chim, AM; Hui, AJ; Lo, AO; Wong, GL; Wong, VW1
Chen, CH; Hsu, YC; Hu, TH; Hung, CH; Lee, CM; Lu, SN; Wang, JH1
Chen, CL; Chen, DS; Chen, PJ; Kao, JH; Liou, JM; Liu, CH; Liu, CJ; Su, TH; Tseng, TC; Yang, HC1
Gadano, A; Marciano, S1
Chang, KC; Chen, CH; Chou, YP; Hu, TH; Hung, CH; Kuo, MT; Kuo, YH; Lu, SN; Tsai, MC; Tseng, PL; Wang, JH1
Agarwal, K; Bruce, M; Carey, I; Considine, A; Heaton, N; Heneghan, M; Lampertico, P; Lim, TY; Manini, MA; Passerini, M; Suddle, A; Whitehouse, G1
Cornberg, M; Crabé, S; Gineste, P; Höner Zu Siederdissen, C; Hui, AJ; Manns, MP; Nieto, GEG; Nitcheu, J; Stepien, S; Su, WW; Sukeepaisarnjaroen, W; Tangkijvanich, P; Trépo, C; Wedemeyer, H1
Dalekos, GN; Gatselis, N; Hadziyannis, E; Manolakopoulos, S; Papatheodoridi, M; Papatheodoridis, GV; Rigopoulou, EI; Vlachogiannakos, J; Xourafas, V; Zachou, K1
Jiang, XW; Li, LJ; Li, YT; Ye, JZ1
Chang, CY; Chen, CC; Hsu, YC; Lin, JT; Mo, LR; Nguyen, MH; Tai, CM; Tanaka, Y; Tseng, CH; Wu, CY; Wu, MS; Yang, TH1
Chen, CH; Hu, TH; Hung, CH; Kuo, MT; Lu, SN; Tsai, KL; Wang, JH1
Akarca, US; Caruntu, FA; Celen, MK; Cornberg, M; Curescu, MG; Dienes, HP; Erhardt, A; Gürel, S; Hardtke, S; Heidrich, B; Idilman, R; Keskin, O; Koch, A; Lüth, S; Manns, MP; Mederacke, I; Papatheodoridis, GV; Port, K; Radu, M; Stift, J; von der Leyen, H; Weber, K; Wedemeyer, H; Wittkop, U; Yalcin, K; Yurdaydin, C; Zeuzem, S1
Huang, R; Wang, J; Wu, C; Wu, W; Yao, R1
Chen, CH1
Bzowej, N; Dinh, P; Flaherty, J; Martin, P; Poordad, F; Pungpapong, S; Rossi, S; Schiano, T; Spivey, J; Subramanian, GM; Teperman, LW1
Goyal, N; Gupta, S; Kumar, A; Taneja, S; Wadhawan, M1
Rao, W; Shen, Z; Xie, M1
Akriviadis, E; Antoniadis, N; Cholongitas, E; Fouzas, I; Goulis, I; Imvrios, G; Papanikolaou, V1
Roche, B; Samuel, D2
Afdhal, NH; Bonder, A; Lau, D; Patwardhan, VR; Sengupta, N1
Akarsu, M; Astarcıoğlu, İ; Hakim, GD; Karademir, S; Unek, T1
Choudhary, NS; Goja, S; Menon, PB; Mohanka, R; Rastogi, A; Saigal, S; Saraf, N; Soin, AS1
Ahmadinejad, Z; Dashti, H; Jafarian, A; Kasraianfard, A; Moini, M; Najafi, A; Nassiri-Toosi, M; Salimi, J1
Chaung, KT; Ha, NB; Kim, LH; Kin, KC; Nguyen, HA; Nguyen, MH; Trinh, HN; Vu, VD1
Fong, TL; Hsieh, MJ; Khemichian, S; Kim, J; Limurti, J; Zhang, SR1
Buti, M; Casillas, R; Esteban, R; Homs, M; Riveiro-Barciela, M; Rodriguez-Frias, F; Salcedo, MT; Tabernero, D1
Bae, HS; Chang, M; Cheung, E; Cho, YW; Chu, D; Cooper, SL; Fong, TL; Han, SB; Jo, KJ; LeDuc, VH; Mena, EA; Mohammed, W; Nguyen, N; Phan, QQ; Tien, A; Tong, MJ; Velasco, A; Yu, AS1
Abradelo, M; Calvo, J; Cambra, F; Castellano, G; Fernández, I; García, A; Hernández, O; Jiménez, C; Loinaz, C; Manrique, A; Manzano, M1
Warpakowski, A1
Chen, YC; Chien, RN; Hu, TH; Jeng, WJ; Liaw, YF; Lin, CL; Sheen, IS1
Akyildiz, M; Balci, D; Cinar, K; Dayangac, M; Gungor, G; Hazinedaroglu, S; Idilman, R; Kalkan, C; Keskin, O; Tokat, Y; Yilmaz, TU1
Hernández, JM; Jarilla, F; Romero, E1
Gómez Espín, R; Muñoz Bertrán, E; Ortega González, I; Pérez Ceballos, E1
Jiang, L; Yan, LN1
Didier, PJ; Michael, H; Mitsuya, H; Murphey-Corb, M; Nyaundi, J; Parniak, MA; Rajakumar, P; Reeve, AB; Sarafianos, SG1
Cholongitas, E; Papatheodoridis, GV1
Berg, T; Hopf, U; Schernick, A; Van Bömmel, F1
Gerlich, WH; Hartmann, H; Schildgen, O1
Schiff, ER; Schreibman, IR1

Reviews

10 review(s) available for tenofovir and Recrudescence

ArticleYear
Finite nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B: From an "option" to an "active recommendation".
    The Kaohsiung journal of medical sciences, 2022, Volume: 38, Issue:4

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Recurrence; Tenofovir; Treatment Outcome

2022
Antiviral prophylaxis against hepatitis B recurrence after liver transplantation: Current concepts.
    Liver international : official journal of the International Association for the Study of the Liver, 2021, Volume: 41, Issue:7

    Topics: Antiviral Agents; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Liver Transplantation; Recurrence; Tenofovir; Treatment Outcome

2021
Why not to stop antiviral treatment in patients with chronic hepatitis B.
    Liver international : official journal of the International Association for the Study of the Liver, 2018, Volume: 38 Suppl 1

    Topics: Alanine Transaminase; Antiviral Agents; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Recurrence; Tenofovir; Treatment Outcome

2018
Hepatitis B reactivation in patients receiving direct-acting antiviral therapy or interferon-based therapy for hepatitis C: A systematic review and meta-analysis.
    World journal of gastroenterology, 2018, Jul-28, Volume: 24, Issue:28

    Topics: Antibiotic Prophylaxis; Antiviral Agents; Coinfection; Disease Progression; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; Humans; Incidence; Interferons; Recurrence; Tenofovir; Treatment Outcome; Virus Activation

2018
Prevention of hepatitis B virus reinfection in liver transplant recipients.
    Intervirology, 2014, Volume: 57, Issue:3-4

    Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Liver; Liver Cirrhosis; Liver Transplantation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors; Tenofovir; Transplant Recipients; Virus Replication

2014
[Hepatitis B reactivation in an HbsAg-negative/anti-HBc-positive patient with B-cell non-Hodgkin lymphoma receiving chemotherapy with rituximab].
    Gastroenterologia y hepatologia, 2010, Volume: 33, Issue:5

    Topics: Adenine; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibody Specificity; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Cyclophosphamide; Fatal Outcome; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunologic Factors; Immunotherapy; Liver Failure; Lymphoma, B-Cell, Marginal Zone; Male; Organophosphonates; Prednisone; Recurrence; Rituximab; Tenofovir; Vincristine; Virus Activation

2010
Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation.
    World journal of gastroenterology, 2010, May-28, Volume: 16, Issue:20

    Topics: Adenine; Antiviral Agents; Asia; Guanine; Hepatitis B; Hepatitis B virus; Humans; Interferons; Lamivudine; Liver Transplantation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors; Tenofovir

2010
High genetic barrier nucleos(t)ide analogue(s) for prophylaxis from hepatitis B virus recurrence after liver transplantation: a systematic review.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2013, Volume: 13, Issue:2

    Topics: Adenine; Antiviral Agents; DNA, Viral; Guanine; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Liver Failure; Liver Transplantation; Nucleotides; Organophosphonates; Recurrence; Tenofovir; Time Factors; Treatment Outcome

2013
[Liver transplantation for complications of hepatitis B].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:2 Pt 2

    Topics: Adenine; Antiviral Agents; Clinical Trials as Topic; Drug Resistance, Viral; Drug Therapy, Combination; Follow-Up Studies; Guanine; Hepatitis B Vaccines; Hepatitis B virus; Hepatitis B, Chronic; Humans; Immunoglobulins; Lamivudine; Liver Cirrhosis; Liver Transplantation; Mutation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors; Tenofovir; Time Factors; Vaccination; Viral Load; Virus Replication

2006
Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues.
    Annals of clinical microbiology and antimicrobials, 2006, Apr-06, Volume: 5

    Topics: Adenine; Antiviral Agents; Drug Therapy, Combination; Guanine; Hepatitis B; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Nucleosides; Nucleotides; Organophosphonates; Recurrence; Tenofovir

2006

Trials

8 trial(s) available for tenofovir and Recrudescence

ArticleYear
Combining Hepatitis B Virus RNA and Hepatitis B Core-Related Antigen: Guidance for Safely Stopping Nucleos(t)ide Analogues in Hepatitis B e Antigen-Positive Patients With Chronic Hepatitis B.
    The Journal of infectious diseases, 2020, 07-23, Volume: 222, Issue:4

    Topics: Adult; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Male; Nucleosides; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Recurrence; Tenofovir; Treatment Outcome; Withholding Treatment

2020
Consolidation period of 18 months no better at promoting off-treatment durability in HBeAg-positive chronic hepatitis B patients with tenofovir disoproxil fumarate treatment than a 12-month period: A prospective randomized cohort study.
    Medicine, 2020, Volume: 99, Issue:18

    Topics: Adult; Alanine Transaminase; Antiviral Agents; Drug Administration Schedule; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Seroconversion; Sustained Virologic Response; Tenofovir; Time Factors

2020
Four-year Outcomes After Cessation of Tenofovir in Immune-tolerant Chronic Hepatitis B Patients.
    Journal of clinical gastroenterology, 2018, Volume: 52, Issue:4

    Topics: Adult; Antiviral Agents; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Hepatitis B, Chronic; Hong Kong; Humans; Immunocompetence; Male; Middle Aged; Recurrence; Tenofovir; Young Adult

2018
Contrasting Timing of Virological Relapse After Discontinuation of Tenofovir or Entecavir in Hepatitis B e Antigen-Negative Patients.
    The Journal of infectious diseases, 2018, 09-22, Volume: 218, Issue:9

    Topics: Adult; Aged; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Tenofovir; Treatment Outcome; Young Adult

2018
Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial.
    The Lancet. Infectious diseases, 2019, Volume: 19, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antiviral Agents; Double-Blind Method; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Europe; Hepatitis D; Hepatitis Delta Virus; Humans; Interferon-alpha; Male; Middle Aged; Placebos; Platelet Count; Polyethylene Glycols; Recombinant Proteins; Recurrence; RNA, Viral; Tenofovir; Treatment Outcome; Young Adult

2019
Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2013, Volume: 19, Issue:6

    Topics: Adenine; Adult; Aged; Antiviral Agents; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Female; Hepatitis B, Chronic; Humans; Immunoglobulins; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir; Treatment Outcome; United States

2013
Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:5

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Drug Administration Schedule; Female; Follow-Up Studies; Guanine; Hepatitis B; Humans; Immunoglobulins; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Recurrence; Tenofovir; Treatment Outcome; Young Adult

2015
[Therapy discontinuation after many years of virus suppression is possible].
    MMW Fortschritte der Medizin, 2015, Aug-20, Volume: 157, Issue:14

    Topics: Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Recurrence; Tenofovir

2015

Other Studies

44 other study(ies) available for tenofovir and Recrudescence

ArticleYear
Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study).
    Gastroenterology, 2022, Volume: 162, Issue:3

    Topics: Adult; Age Factors; Antiviral Agents; Asian People; Cohort Studies; DNA, Viral; Female; Follow-Up Studies; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Middle Aged; Nucleosides; Race Factors; Recurrence; Retreatment; Tenofovir; White People

2022
Earlier and Higher Rate of Hepatitis B Virus Relapse After Discontinuing Tenofovir Versus Entecavir in Hepatitis B e Antigen-Positive Patients.
    The Journal of infectious diseases, 2022, 06-01, Volume: 225, Issue:11

    Topics: Antiviral Agents; DNA, Viral; Guanine; Hepatitis B Core Antigens; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Recurrence; Tenofovir; Treatment Outcome

2022
Kinetics in HBsAg after Stopping Entecavir or Tenofovir in Patients with Virological Relapse but Not Clinical Relapse.
    Viruses, 2022, 05-30, Volume: 14, Issue:6

    Topics: Antiviral Agents; DNA, Viral; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kinetics; Recurrence; Tenofovir; Treatment Outcome

2022
Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis B.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2023, Volume: 21, Issue:6

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Recurrence; Tenofovir; Treatment Outcome

2023
A switch from tenofovir to entecavir prior to hepatitis B treatment cessation is associated with a reduced risk of off-therapy relapse: An observational study.
    Journal of gastroenterology and hepatology, 2022, Volume: 37, Issue:11

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Recurrence; Symptom Flare Up; Tenofovir; Treatment Outcome; Withholding Treatment

2022
Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir Cessation.
    Digestive diseases and sciences, 2023, Volume: 68, Issue:2

    Topics: Adenine; Alanine; Antiviral Agents; DNA, Viral; Hepatitis B, Chronic; Humans; Recurrence; Retreatment; Retrospective Studies; Tenofovir; Treatment Outcome

2023
Distinct Relapse Patterns Between HBeAg-Negative Patients Stopping Tenofovir and Entecavir.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2023, Volume: 21, Issue:5

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B e Antigens; Hepatitis B virus; Humans; Recurrence; Tenofovir; Treatment Outcome

2023
Combined baseline HBcrAg and end-of-treatment HBsAg predict HBV relapse after entecavir or tenofovir cessation.
    The Journal of antimicrobial chemotherapy, 2023, 02-01, Volume: 78, Issue:2

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Recurrence; Tenofovir; Treatment Outcome; Withholding Treatment

2023
HBV relapse rates in patients who discontinue tenofovir disoproxil fumarate with or without switching to tenofovir alafenamide.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2023, Volume: 55, Issue:6

    Topics: Adenine; Alanine; Hepatitis B virus; Humans; Recurrence; Tenofovir

2023
Post-treatment HBsAg decline predicts high rate of HBsAg loss after stopping entecavir or tenofovir in HBeAg-negative patients without retreatment.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2023, Volume: 55, Issue:9

    Topics: Antiviral Agents; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Recurrence; Retreatment; Tenofovir

2023
Serum cytokine profiles predict outcomes of chronic hepatitis B patients discontinuing entecavir or tenofovir therapy.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2023, Volume: 122, Issue:7

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Interferon-gamma; Interleukin-18; Interleukin-7; Recurrence; Tenofovir; Treatment Outcome

2023
Higher rate of HBsAg loss after discontinuation of tenofovir than entecavir in patients with chronic hepatitis B.
    Alimentary pharmacology & therapeutics, 2023, Volume: 58, Issue:3

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Recurrence; Retrospective Studies; Tenofovir; Treatment Outcome

2023
Higher HBeAg-reversion virological relapse and lower sustained remission after treatment cessation in tenofovir-treated HBeAg-positive patients.
    Journal of medical virology, 2023, Volume: 95, Issue:11

    Topics: Antiviral Agents; DNA, Viral; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Recurrence; Retrospective Studies; Tenofovir; Treatment Outcome; Withholding Treatment

2023
Incidence and predictors of retreatment in chronic hepatitis B patients after discontinuation of entecavir or tenofovir treatment.
    PloS one, 2019, Volume: 14, Issue:10

    Topics: Adult; Antiviral Agents; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Incidence; Male; Middle Aged; Prospective Studies; Recurrence; Retreatment; Retrospective Studies; Taiwan; Tenofovir; Treatment Outcome; Withholding Treatment

2019
Incidence and Factors Associated With HBV Relapse After Cessation of Entecavir or Tenofovir in Patients With HBsAg Below 100 IU/mL.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2020, Volume: 18, Issue:12

    Topics: Antigens, Surface; Antiviral Agents; DNA, Viral; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Incidence; Recurrence; Tenofovir; Treatment Outcome

2020
High Risk of Clinical Relapse in Patients With Chronic Hepatitis B Virus Infection After Cessation of Prophylactic Antiviral Therapy for Rituximab-Containing Chemotherapy.
    The Journal of infectious diseases, 2020, 09-14, Volume: 222, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Immunological; Antiviral Agents; DNA, Viral; Female; Guanine; Hematologic Neoplasms; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Failure; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Factors; Rituximab; Tenofovir; Viral Load; Virus Activation; Withholding Treatment; Young Adult

2020
Prevention of HBV Recurrence After Liver Transplant: Long-Term Results.
    Transplantation proceedings, 2021, Volume: 53, Issue:5

    Topics: Adult; Antiviral Agents; Carcinoma, Hepatocellular; Drug Administration Schedule; Female; Guanine; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Humans; Immunoglobulins; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recurrence; Retrospective Studies; Tenofovir

2021
Predictors of Virological Suppression After Clinical Relapse in Patients Who Discontinued Entecavir or Tenofovir.
    Digestive diseases and sciences, 2022, Volume: 67, Issue:7

    Topics: Antiviral Agents; DNA, Viral; Guanine; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Recurrence; Tenofovir; Treatment Outcome

2022
The incidence and predictors of HBV relapse after cessation of tenofovir therapy in chronic hepatitis B patients.
    Journal of viral hepatitis, 2018, Volume: 25, Issue:5

    Topics: Adult; Aged; Antiviral Agents; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Incidence; Male; Middle Aged; Recurrence; Retrospective Studies; Risk Assessment; Tenofovir

2018
Distinct Relapse Rates and Risk Predictors After Discontinuing Tenofovir and Entecavir Therapy.
    The Journal of infectious diseases, 2018, 03-28, Volume: 217, Issue:8

    Topics: Adult; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Risk Factors; Tenofovir

2018
Role of hepatitis B surface antigen in hepatitis B virus relapse after entecavir or tenofovir prophylaxis in patients undergoing cancer chemotherapy.
    Journal of gastroenterology and hepatology, 2018, Volume: 33, Issue:10

    Topics: Adult; Aged; Biomarkers; Female; Follow-Up Studies; Guanine; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms; Predictive Value of Tests; Recurrence; Secondary Prevention; Tenofovir; Time Factors

2018
Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2018, Volume: 50, Issue:9

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Humans; Immunoglobulins; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Recurrence; Retrospective Studies; Tenofovir; Young Adult

2018
DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long-term therapy before HBsAg loss in non-cirrhotic HBeAg-negative chronic hepatitis B.
    Antiviral therapy, 2018, Volume: 23, Issue:8

    Topics: Adult; Aged; Female; Follow-Up Studies; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Liver Function Tests; Male; Middle Aged; Proportional Hazards Models; Recurrence; Retreatment; Tenofovir; Treatment Outcome; Viral Load

2018
Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk.
    Alimentary pharmacology & therapeutics, 2019, Volume: 49, Issue:1

    Topics: Adult; Antiviral Agents; Biomarkers; DNA, Viral; Female; Guanine; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Incidence; Male; Middle Aged; Prospective Studies; Recurrence; Tenofovir; Withholding Treatment

2019
Hepatitis B virus relapse rates in chronic hepatitis B patients who discontinue either entecavir or tenofovir.
    Alimentary pharmacology & therapeutics, 2019, Volume: 49, Issue:2

    Topics: Adult; Antiviral Agents; Female; Guanine; Hepatitis B, Chronic; Humans; Male; Medication Adherence; Middle Aged; Prospective Studies; Recurrence; Retrospective Studies; Tenofovir; Viral Load; Young Adult

2019
Letter: distinct hepatitis B virus relapse rates after discontinuing tenofovir and entecavir therapy in chronic hepatitis B patients.
    Alimentary pharmacology & therapeutics, 2019, Volume: 49, Issue:8

    Topics: Antiviral Agents; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Recurrence; Tenofovir

2019
Letter: distinct hepatitis B virus relapse rates after discontinuing tenofovir and entecavir therapy in chronic hepatitis B patients-author's reply.
    Alimentary pharmacology & therapeutics, 2019, Volume: 49, Issue:8

    Topics: Antiviral Agents; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Recurrence; Tenofovir

2019
Living related liver transplantation for hepatitis B-related liver disease without hepatitis B immune globulin prophylaxis.
    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 2013, Volume: 19, Issue:9

    Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; DNA, Viral; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunosuppression Therapy; Immunosuppressive Agents; Lamivudine; Liver Transplantation; Living Donors; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir; Treatment Outcome

2013
Tenofovir disoproxil fumarate rescue therapy for HBV recurrence in two liver transplant recipients with previous multiple nucleo(s/t)ide treatment failures.
    Transplant international : official journal of the European Society for Organ Transplantation, 2014, Volume: 27, Issue:10

    Topics: Adenine; Aged; Follow-Up Studies; Graft Rejection; Graft Survival; Hepatitis B; Humans; Liver Failure; Liver Function Tests; Liver Transplantation; Male; Nucleotides; Organophosphonates; Recurrence; Retreatment; Risk Assessment; Tenofovir; Transplant Recipients; Treatment Failure; Treatment Outcome

2014
New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence.
    Transplant international : official journal of the European Society for Organ Transplantation, 2014, Volume: 27, Issue:10

    Topics: Adenine; Adult; Cohort Studies; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Guanine; Hepatitis B, Chronic; Humans; Immunoglobulins; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Male; Organophosphonates; Prospective Studies; Recurrence; Retreatment; Risk Assessment; Statistics, Nonparametric; Tenofovir; Transplantation Immunology; Treatment Outcome

2014
Treatment cessation in noncirrhotic, e-antigen negative chronic hepatitis B is safe and effective following prolonged anti-viral suppression with nucleosides/nucleotides.
    Alimentary pharmacology & therapeutics, 2014, Volume: 40, Issue:7

    Topics: Adenine; Adult; Antiviral Agents; Female; Guanine; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Nucleosides; Nucleotides; Organophosphonates; Recurrence; Tenofovir; Withholding Treatment; Young Adult

2014
The efficacy and safety of tenofovir in the prevention of hepatitis B virus recurrence following liver transplantation.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2014, Volume: 25, Issue:6

    Topics: Adenine; Antiviral Agents; End Stage Liver Disease; Female; Hepatitis B; Humans; Immunoglobulins; Liver Transplantation; Male; Middle Aged; Organophosphonates; Postoperative Complications; Recurrence; Retrospective Studies; Tenofovir; Treatment Outcome

2014
Low-dose short-term hepatitis B immunoglobulin with high genetic barrier antivirals: the ideal post-transplant hepatitis B virus prophylaxis?
    Transplant infectious disease : an official journal of the Transplantation Society, 2015, Volume: 17, Issue:3

    Topics: Adenine; Adult; Antiviral Agents; Carcinoma, Hepatocellular; Cohort Studies; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir

2015
Efficacy and safety of lamivudine or tenofovir plus intramuscular hepatitis B immunoglobulin in prevention of hepatitis B virus reinfection after liver transplant.
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation, 2015, Volume: 13 Suppl 1

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis B; Hepatitis B virus; Humans; Immunoglobulins; Injections, Intramuscular; Lamivudine; Liver Failure; Liver Transplantation; Male; Middle Aged; Prospective Studies; Recurrence; Tenofovir; Time Factors; Treatment Outcome; Virus Activation; Young Adult

2015
Tenofovir monotherapy after achieving complete viral suppression on entecavir plus tenofovir combination therapy.
    European journal of gastroenterology & hepatology, 2015, Volume: 27, Issue:8

    Topics: Adult; Antiviral Agents; Biomarkers; Chi-Square Distribution; DNA, Viral; Drug Administration Schedule; Drug Therapy, Combination; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Logistic Models; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Odds Ratio; Recurrence; Retrospective Studies; Risk Factors; Tenofovir; Time Factors; Treatment Outcome; Viral Load

2015
Nucleoside-Nucleotide Analog Combination Therapy Is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation.
    Digestive diseases and sciences, 2015, Volume: 60, Issue:9

    Topics: Adenine; Adult; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Female; Guanine; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Prospective Studies; Recurrence; Tenofovir

2015
Tenofovir discontinuation after long-term viral suppression in HBeAg negative chronic hepatitis B. Can HBsAg levels be useful?
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2015, Volume: 68

    Topics: Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Monitoring; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B, Chronic; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Tenofovir; Treatment Outcome; Withholding Treatment

2015
Durability of Hepatitis B e Antigen Seroconversion in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir.
    Digestive diseases and sciences, 2015, Volume: 60, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Biomarkers; DNA, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Tenofovir; Time Factors; Treatment Outcome; Viral Load; Young Adult

2015
Clinical Relapse After Cessation of Tenofovir Therapy in Hepatitis B e Antigen-Negative Patients.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2016, Volume: 14, Issue:12

    Topics: Adult; Aged; Antiviral Agents; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Incidence; Male; Middle Aged; Prospective Studies; Recurrence; Retrospective Studies; Sustained Virologic Response; Tenofovir; Withholding Treatment

2016
The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence.
    Clinical transplantation, 2016, Volume: 30, Issue:10

    Topics: Adenine; Administration, Oral; Adult; Aged; Antiviral Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B, Chronic; Humans; Immunoglobulins; Immunologic Factors; Kaplan-Meier Estimate; Lamivudine; Liver Transplantation; Male; Middle Aged; Organophosphonates; Postoperative Complications; Proportional Hazards Models; Recurrence; Retrospective Studies; Tenofovir; Treatment Outcome

2016
[Renal tuberculosis and human immunodeficiency virus infection].
    Enfermedades infecciosas y microbiologia clinica, 2009, Volume: 27, Issue:6

    Topics: Acute Kidney Injury; Adenine; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antitubercular Agents; Fatal Outcome; Humans; Kidney Diseases; Male; Middle Aged; Multiple Organ Failure; Organophosphonates; Pneumocystis carinii; Pneumonia, Pneumocystis; Recurrence; Renal Dialysis; Tenofovir; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Renal

2009
Response of simian immunodeficiency virus to the novel nucleoside reverse transcriptase inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine in vitro and in vivo.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:9

    Topics: Adenine; Animals; Antiviral Agents; Cells, Cultured; Deoxyadenosines; Deoxycytidine; Emtricitabine; Leukocytes, Mononuclear; Macaca mulatta; Male; Mutation; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Simian Acquired Immunodeficiency Syndrome; Simian Immunodeficiency Virus; Tenofovir; Viral Load; Zidovudine

2012
Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis B reactivation.
    Gastroenterology, 2003, Volume: 124, Issue:2

    Topics: Adenine; Antiviral Agents; Drug Resistance, Microbial; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Recurrence; Reverse Transcriptase Inhibitors; Tenofovir; Virus Activation

2003
Replacement of tenofovir with adefovir may result in reactivation of hepatitis B virus replication.
    Scandinavian journal of gastroenterology, 2006, Volume: 41, Issue:2

    Topics: Adenine; Antiviral Agents; Follow-Up Studies; Hepatitis B virus; Hepatitis B, Chronic; Humans; Male; Middle Aged; Organophosphonates; Recurrence; Reverse Transcriptase Inhibitors; Tenofovir; Virus Replication

2006